Suppr超能文献

AKAP13是一种RhoA GTP酶特异性鸟嘌呤交换因子,是Toll样受体2(TLR2)信号传导的新型调节因子。

AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling.

作者信息

Shibolet Oren, Giallourakis Cosmas, Rosenberg Ian, Mueller Tobias, Xavier Ramnik J, Podolsky Daniel K

机构信息

Gastroenterology Unit, Center for Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

J Biol Chem. 2007 Nov 30;282(48):35308-17. doi: 10.1074/jbc.M704426200. Epub 2007 Sep 18.

Abstract

Members of the guanine exchange factor (GEF) family of scaffold proteins are involved in the integration of signal flow downstream of many receptors in adaptive immunity. However, the full complement of GEFs that function downstream of Toll-like receptors (TLRs) requires further identification and functional understanding. By systematically integrating expression profiles from immune and epithelial cells with functional studies, we demonstrate that protein kinase A anchoring protein 13 (AKAP13), a scaffold protein with GEF activity, is an activator of NF-kappaB downstream of TLR2 signaling. Stimulation of the human macrophage cell line THP-1 and epithelial cells with a TLR2 ligand caused a significant up-regulation in AKAP13 mRNA, corresponding to an increase in protein expression. Analysis of TLR2 reporter cell lines deficient in AKAP13 expression revealed significantly reduced NF-kappaB activation and reduced secretion of interleukin-8 and MCP-1 in response to specific ligand stimulation. Furthermore, NF-kappaB activation was partially inhibited by a GEF-deficient AKAP13 mutant. AKAP13 was also involved in phosphorylation of JNK but not of extracellular signal-regulated kinase ERK1 and -2 following ligand stimulation. Together, our results suggest that AKAP13 plays a role in TLR2-mediated NF-kappaB activation and suggest that GEF-containing scaffold proteins may confer specificity to innate immune responses downstream of TLRs.

摘要

支架蛋白鸟嘌呤核苷酸交换因子(GEF)家族的成员参与了适应性免疫中许多受体下游信号流的整合。然而,在Toll样受体(TLR)下游发挥作用的GEF的完整组成仍需进一步鉴定和功能研究。通过系统地将免疫细胞和上皮细胞的表达谱与功能研究相结合,我们证明蛋白激酶A锚定蛋白13(AKAP13),一种具有GEF活性的支架蛋白,是TLR2信号下游NF-κB的激活剂。用TLR2配体刺激人巨噬细胞系THP-1和上皮细胞会导致AKAP13 mRNA显著上调,相应地蛋白表达增加。对缺乏AKAP13表达的TLR2报告细胞系的分析显示,在特定配体刺激下,NF-κB激活显著降低,白细胞介素-8和单核细胞趋化蛋白-1的分泌减少。此外,GEF缺陷型AKAP13突变体部分抑制了NF-κB激活。AKAP13还参与配体刺激后JNK的磷酸化,但不参与细胞外信号调节激酶ERK1和ERK2的磷酸化。总之,我们的结果表明AKAP13在TLR2介导的NF-κB激活中起作用,并表明含GEF的支架蛋白可能赋予TLR下游先天免疫反应特异性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验